Besides the inflammatory detection in FTD, PET techniques using tau radioligands have recently shown potential as a specific biomarker of FTD, given that [18F] AV-1451 was abnormally distributed in patients with bvFTD caused by a specific mutation in the tau gene. This evidence concerns the gene MAPT and behavioral variant of frontotemporal dementia.